Our study found that there were no differences in age, AMH, basal FSH, LH, E2, and P levels, endometrium thickness, and E2 and P levels on the progesterone administration or HCG trigger day between hyperlipidemia and control groups. This evidence concerns the gene AMH and hyperlipidemia.